GlassScriptPhysician profile
Erin Floyd
NPI 1508127911
$4,592.09
in general payments reported to CMS, 2019-2025
38 companies · $959 in 2025
The $959 reported for 2025 was more than what 80% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $851 · 2022: $918 · 2023: $1,044 · 2024: $820 · 2025: $959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,791 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,790.57 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $644.06 | 2021-2025 | Airsupra, Farxiga |
| Abbvie INC. | $593.51 | 2021-2025 | |
| Lilly USA, LLC | $489.95 | 2021-2025 | Mounjaro, Jardiance, Trulicity |
| Novo Nordisk INC | $430.44 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $405.59 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $222.28 | 2022-2025 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $207.96 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $186.03 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $171.64 | 2022-2025 | |
| Dexcom, INC. | $145.20 | 2024-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $136.84 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.46 | 2021-2025 | Jardiance |
| Amgen INC. | $88.44 | 2021-2024 | Otezla, Repatha, Aimovig |
| Mylan Specialty L.P. | $76.61 | 2022-2023 | Yupelri |
| Sanofi-Aventis U.S. LLC | $69.18 | 2022-2023 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Floyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.